Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02040025 · ClinicalTrials.gov registry record
Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus
A clinical trial, sponsored by David Grant U.S. Air Force Medical Center.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02040025: Clinical Trial study, sponsored by David Grant U.S. Air Force Medical Center.
NCT02040025 is a clinical trial that was terminated before completion, run by David Grant U.S. Air Force Medical Center. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02040025 was terminated before completion, sponsored by David Grant U.S. Air Force Medical Center.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this proposed Department of Defense study is to evaluate the effect of Enhanced External Counterpulsation (EECP) on circulation, blood glucose control and blood pressure of type 2 diabetic patients receiving EECP therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-10 |
Why NCT02040025 stopped before completion
NCT02040025 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02040025 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02040025 about?
NCT02040025 is a clinical study titled "Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus". The purpose of this proposed Department of Defense study is to evaluate the effect of Enhanced External Counterpulsation (EECP) on circulation, blood glucose control and blood pressure of type 2 diabetic patients receiving EECP therapy.
What is the current status of trial NCT02040025?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2014-04. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT02040025?
This trial is sponsored by David Grant U.S. Air Force Medical Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia